Indication

Atrophy of vulva

Atrophy of the vulva is a degenerative dermatologic and gynecologic condition characterized by progressive thinning, drying, and loss of elasticity of the external female genitalia. Read more about Atrophy of vulva

107 drugs 55 manufacturers

Advertisement

Drugs that treat it

Common Atrophy of vulva therapies.

Showing 64–72 of 107 drugs

ESTRADIOL

ESTROGENS·METASTATIC BREAST CARCINOMA·+9
NORTHSTAR RX LL
Filter & compare in the drug finder →Opens the drug finder with Atrophy of vulva preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Atrophy of vulva.

Atrophy of the vulva is a degenerative dermatologic and gynecologic condition characterized by progressive thinning, drying, and loss of elasticity of the external female genitalia.

Most commonly affecting postmenopausal individuals or those in hypoestrogenic states, it frequently manifests as part of vulvovaginal atrophy and the genitourinary syndrome of menopause.

Pathophysiologically driven by reduced circulating estrogen, the condition results in collagen depletion, diminished vascular perfusion, and structural regression such as flattening of the labia, loss of subcutaneous fat, and tissue friability.

Clinically, affected patients present with localized dryness, pruritus, burning, introital stenosis, and dyspareunia.

Personalize your experience

Follow Atrophy of vulva and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it